Home › Myelofibrosis › Connecticut › New Haven
Myelofibrosis clinical trials in New Haven, CT
4 studies for Myelofibrosis are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Yale Cancer Center, New Haven
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
RecruitingPhase 3
- Yale University School Of Medicine, New Haven
Pacritinib Effectiveness in Real-world Settings
RecruitingObservational study
- Yale School of Medicine, New Haven
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RecruitingPhase 1/2
- Yale School of Medicine, New Haven
Myelofibrosis trials in other cities
- New York City, NY21 studies
- Houston, TX20 studies
- Boston, MA13 studies
- Durham, NC13 studies
- Columbus, OH12 studies
- Seattle, WA12 studies
- Tampa, FL11 studies
- Nashville, TN11 studies
- Miami, FL11 studies
- Salt Lake City, UT11 studies
- Ann Arbor, MI10 studies
- Atlanta, GA10 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer40 studies
- Breast Cancer38 studies
- Cancer (all types)35 studies
- Lung Cancer24 studies
- Colorectal Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Metastatic Cancer22 studies
- Prostate Cancer22 studies
- Ovarian Cancer20 studies
- Opioid Overdose19 studies
- Acute Myeloid Leukemia18 studies
- Alcohol Use Disorder (AUD)18 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.